← Back to Screener
ENDRA Life Sciences Inc. Common Stock (NDRA)
Price$6.01
Favorite Metrics
Price vs S&P 500 (26W)-9.98%
Price vs S&P 500 (4W)76.01%
Market Capitalization$7.46M
All Metrics
Book Value / Share (Quarterly)$1.92
P/TBV (Annual)21.12x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-6.97
Price vs S&P 500 (YTD)37.14%
Gross Margin (TTM)51.35%
Net Profit Margin (TTM)-2016.22%
EPS (TTM)$-8.52
10-Day Avg Trading Volume0.02M
EPS Excl Extra (TTM)$-8.52
EPS (Annual)$-8.93
ROI (Annual)-310.93%
Gross Margin (Annual)100.00%
Net Profit Margin (5Y Avg)-20124.55%
Cash / Share (Quarterly)$0.65
ROA (Last FY)-182.35%
EBITD / Share (TTM)$-8.88
ROE (5Y Avg)-245.08%
Operating Margin (TTM)-1921.62%
Cash Flow / Share (Annual)$-6.97
P/B Ratio3.30x
P/B Ratio (Quarterly)2.34x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)18.11x
Net Interest Coverage (TTM)-50.00x
ROA (TTM)-238.29%
EPS Incl Extra (Annual)$-8.93
Current Ratio (Annual)1.29x
Quick Ratio (Quarterly)1.02x
3-Month Avg Trading Volume0.09M
52-Week Price Return91.04%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$0.21
P/S Ratio (Annual)746.19x
Asset Turnover (Annual)0.00x
52-Week High$11.96
Operating Margin (5Y Avg)-18450.33%
EPS Excl Extra (Annual)$-8.93
CapEx CAGR (5Y)106.68%
Tangible BV CAGR (5Y)6.43%
26-Week Price Return-1.23%
Quick Ratio (Annual)1.02x
13-Week Price Return39.43%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)1.29x
Enterprise Value$6.7
Asset Turnover (TTM)0.06x
Book Value / Share Growth (5Y)-14.53%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)0.00x
Pretax Margin (Annual)-98000.00%
Cash / Share (Annual)$0.65
3-Month Return Std Dev100.24%
Gross Margin (5Y Avg)62.27%
Net Income / Employee (TTM)$-0
ROE (Last FY)-310.93%
EPS Basic Excl Extra (Annual)$-8.93
Receivables Turnover (TTM)2.00x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-8.52
ROI (TTM)-496.85%
P/S Ratio (TTM)20.17x
Pretax Margin (5Y Avg)-20124.55%
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$0.21
Price vs S&P 500 (52W)55.95%
Year-to-Date Return41.28%
5-Day Price Return23.31%
EPS Normalized (Annual)$-8.93
ROA (5Y Avg)-163.84%
Net Profit Margin (Annual)-98000.00%
Month-to-Date Return37.63%
Cash Flow / Share (TTM)$-2.35
EBITD / Share (Annual)$-8.87
Operating Margin (Annual)-90200.00%
LT Debt / Equity (Annual)0.00x
ROI (5Y Avg)-244.69%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-8.52
P/TBV (Quarterly)21.12x
P/B Ratio (Annual)2.34x
Inventory Turnover (TTM)0.00x
Pretax Margin (TTM)-2016.22%
Book Value / Share (Annual)$1.92
Price vs S&P 500 (13W)36.57%
Beta0.06x
Revenue / Share (TTM)$0.00
ROE (TTM)-496.85%
52-Week Low$2.90
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.14
4.14
4.14
4.14
Industry Peers — Electromedical Equipment(29)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
NDRAENDRA Life Sciences Inc. Common Stock | 20.17x | — | 51.35% | -1921.62% | $6.01 |
MDTMedtronic plc | 3.13x | 3.01% | 65.16% | 17.00% | $85.00 |
MASIMasimo Corporation | 6.11x | 5.95% | 61.90% | 20.30% | $178.45 |
TMDXTransMedics Group, Inc. Common Stock | 6.56x | 88.21% | 59.92% | 17.93% | $113.13 |
LIVNLivaNova PLC Ordinary Shares | 2.59x | 8.24% | 68.04% | 14.09% | $65.81 |
ITGRInteger Holdings Corporation | 1.66x | 11.55% | 27.39% | 11.90% | $89.32 |
AXGNAxogen, Inc. Common Stock | 8.90x | 14.93% | 74.31% | -3.49% | $37.23 |
CNMDCONMED Corporation | 0.88x | 9.77% | 54.59% | 7.46% | $39.68 |
BLFSBioLife Solutions Inc. | 10.84x | 14.87% | 64.56% | -17.26% | $22.19 |
INMDInMode Ltd. Ordinary Shares | 2.51x | 12.45% | 78.54% | 23.05% | $14.57 |
CBLLCeriBell, Inc. Common Stock | 8.96x | — | 87.89% | -65.57% | $21.13 |
About
ENDRA Life Sciences develops Thermo Acoustic Enhanced Ultrasound (TAEUS), a point-of-care imaging technology that delivers MRI-quality tissue visualization at ultrasound cost using existing ultrasound systems globally. The company is initially targeting assessment of fatty liver disease (NAFLD/NASH), which affects over 1 billion people worldwide with no practical diagnostic tools currently available. Additional applications include thermal imaging during energy-based surgical procedures.